Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Merkel Cell

Explore clinical trials studying Carcinoma, Merkel Cell. Study availability and eligibility vary by location and protocol.

103 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Merkel Cell trial results

Completed

Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation

NCT02196961

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University Hospital Essen, Dermatology Essen, North Rhine-Westphalia, Germany
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Elbeklinikum Buxtehude Buxtehude, Germany
  • University Hospital Dresden, Dermatology Dresden, Germany
View all 20 locations
View Trial Details
Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

NCT04160065

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1

NCT04393753

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • UZ Leuven Leuven, Belgium
  • Bordeaux Hôpital Saint Andre Bordeaux, France
  • Hôpital Ambroise Paré - Boulogne-Billancourt Boulogne-Billancourt, France
  • CHU Nantes - Hotel Dieu Nantes, France
View all 22 locations
View Trial Details
Completed

Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC

NCT05253144

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • North Bristol NHS Trust Bristol, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Tayside Dundee, United Kingdom
View all 14 locations
View Trial Details
Completed

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

NCT02155647

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +13 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute - West LA Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa, Florida, United States
View all 61 locations
View Trial Details

Related conditions